Kardia 12L
Contact Us
Don't hesitate to contact us via email or phone to learn more.
Email: enquiry@mellica.com
Phone: +852 34695611
Patient-Centric AFib Screening
Early detection of arrhythmias is possible with Kardia screening program, a home-based screening program that is easy for at-risk members to follow, for short or long-term monitoring.
AFIB PREVALENCE IS SIGNIFICANTLY UNDETECTED
40%
of AFib patients are asymptomatic
20%
of patients’ first clinical manifestation of AFib is stroke²
$8.7k
AFib can increase annual health care costs by $8700 per patient³
KardiaMobile®
Proven to detect undiagnosed AFib & reduce total cost of care⁴
#1 patient-preferred personal ECG brand with high satisfaction
Easy to use for long-term monitoring with no uncomfortable patches or wires
FDA-cleared, instant heart rhythm determination gives patients peace of mind
Telecardiology coverage nationwide with same-day appointments availabled
KardiaMobile® detected more AFib than routine care
REHEARSE-AF Study found a nearly 4x increase in AFib detection in KardiaMobile group compared to routine care alone.⁴
- RCT (n=1001) using KardiaMobile for AFib screening
- Patients aged ≥ 65 with CHADS-VASc score ≥ 2
- ECGs captured 2x weekly over 12 months (or if symptomatic)
How It Works
Offer an innovative supplemental benefit program designed to improve risk adjustment accuracy and support quality initiatives
References
- Boriani, et al. “Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry.” Am J Med vol. 128,5 (2015): 509-518.2.
- Tayal, A Het al. “Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke.” Neurology vol. 71,21 (2008): 1696-701.
- Calkins, Het al. “HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.” Heart Rhythm vol. 14, 10 (2017): e275-444.
- Halcox, J P Jet al. “Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.” Circulation vol. 136,19 (2017): 1784-1794.
Contact Us
Don't hesitate to contact us via email or phone to learn more.
Email: enquiry@mellica.com
Phone: +852 34695611